Based on the provided evidence, CAR T cells manufactured with interleukin-15 are predicted to have a more robust and polyfunctional cytokine release profile, including higher secretion of key effector cytokines like IFN-γ and TNF-α, compared to T cells manufactured without interleukin-15.